Nonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment Strategy

摘要

Studies have shown that nonalcoholic fatty liver disease (NAFLD) is strongly associated with several metabolic disorders and diseases,such as obesity,type 2 diabetes mellitus,and dyslipidemia.In NAFLD,dyslipidemia is manifested as increased serum triglyceride and low-density lipoprotein cholesterol levels and decreased high-density lipoprotein cholesterol levels,all of which are key risk factors for cardiovascular disease (CVD).CVD is a leading cause of mortality in NAFLD patients.Thus,implementation of an aggressive therapeutic strategy for dyslipidemia with hypolipidemic agents may mitigate the risk for CVD among NAFLD patients.Here,we provide a current review of literature regarding NAFLD,with particular emphasis on dyslipidemia and available treatment options.